Stock comparison

RGCvsRPRX

Regencell Bioscience Holdings LtdvsRoyalty Pharma PLC. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RGC

Regencell Bioscience Holdings Ltd

$28.31

+70.54%

Pharmaceuticals$11.9BNASDAQ

RPRX

Royalty Pharma PLC

$49.64

+29.34%

Pharmaceuticals$27.1BNASDAQ

60-day price, rebased to 100

RGC -12.33% · RPRX +19.10%

Round-by-round

RGC 1·RPRX 3· 2ties

Tie

Valuation upside

— vs -57.50% to DCF fair value

EdgeRGC

Balance-sheet strength

Altman Z 32636.93 vs 2.25

EdgeRPRX

Fundamental quality

Piotroski 4.00 vs 5.00 (of 9)

Tie

Growth + margins

Rule-of-40 — vs 109.80

EdgeRPRX

60-day momentum

-12.33% vs +19.10% price return

EdgeRPRX

Market-cap liquidity

$11.9B vs $27.1B

Verdict

Across6categories,RPRXtakes the edge with3wins to1 (and 2 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRGCorRPRX

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.